nodes	percent_of_prediction	percent_of_DWPC	metapath
Sorafenib—liver cancer—jejunal cancer	0.912	1	CtDrD
Sorafenib—KIT—myenteric nerve plexus—jejunal cancer	0.00787	0.0895	CbGeAlD
Sorafenib—CDKL3—endocrine gland—jejunal cancer	0.00269	0.0306	CbGeAlD
Sorafenib—CDKL2—endocrine gland—jejunal cancer	0.00246	0.028	CbGeAlD
Sorafenib—MAPK15—endocrine gland—jejunal cancer	0.00222	0.0252	CbGeAlD
Sorafenib—CDK7—lymphoid tissue—jejunal cancer	0.00159	0.018	CbGeAlD
Sorafenib—TIE1—smooth muscle tissue—jejunal cancer	0.00157	0.0178	CbGeAlD
Sorafenib—HIPK3—pancreas—jejunal cancer	0.00155	0.0176	CbGeAlD
Sorafenib—HIPK4—endocrine gland—jejunal cancer	0.00149	0.017	CbGeAlD
Sorafenib—ZAK—lymphoid tissue—jejunal cancer	0.00137	0.0156	CbGeAlD
Sorafenib—CDK7—endocrine gland—jejunal cancer	0.00129	0.0147	CbGeAlD
Sorafenib—AURKC—endocrine gland—jejunal cancer	0.00127	0.0145	CbGeAlD
Sorafenib—MAP3K7—smooth muscle tissue—jejunal cancer	0.00121	0.0138	CbGeAlD
Sorafenib—EPHA6—endocrine gland—jejunal cancer	0.00118	0.0134	CbGeAlD
Sorafenib—MKNK2—smooth muscle tissue—jejunal cancer	0.00117	0.0133	CbGeAlD
Sorafenib—FLT3—lymphoid tissue—jejunal cancer	0.00114	0.013	CbGeAlD
Sorafenib—ZAK—endocrine gland—jejunal cancer	0.00112	0.0127	CbGeAlD
Sorafenib—HIPK3—endocrine gland—jejunal cancer	0.00109	0.0124	CbGeAlD
Sorafenib—MKNK2—pancreas—jejunal cancer	0.00108	0.0123	CbGeAlD
Sorafenib—RALBP1—smooth muscle tissue—jejunal cancer	0.00106	0.012	CbGeAlD
Sorafenib—FLT4—lymphoid tissue—jejunal cancer	0.00104	0.0118	CbGeAlD
Sorafenib—FLT1—smooth muscle tissue—jejunal cancer	0.00101	0.0115	CbGeAlD
Sorafenib—RAF1—smooth muscle tissue—jejunal cancer	0.001	0.0114	CbGeAlD
Sorafenib—RALBP1—pancreas—jejunal cancer	0.000979	0.0111	CbGeAlD
Sorafenib—PDGFRA—smooth muscle tissue—jejunal cancer	0.000944	0.0107	CbGeAlD
Sorafenib—MKNK2—lymphoid tissue—jejunal cancer	0.000938	0.0107	CbGeAlD
Sorafenib—FLT1—pancreas—jejunal cancer	0.000932	0.0106	CbGeAlD
Sorafenib—FLT3—endocrine gland—jejunal cancer	0.000931	0.0106	CbGeAlD
Sorafenib—RAF1—pancreas—jejunal cancer	0.000926	0.0105	CbGeAlD
Sorafenib—MKNK1—lymphoid tissue—jejunal cancer	0.000926	0.0105	CbGeAlD
Sorafenib—RET—lymphoid tissue—jejunal cancer	0.000915	0.0104	CbGeAlD
Sorafenib—MAPK11—lymph node—jejunal cancer	0.00091	0.0103	CbGeAlD
Sorafenib—CDK7—lymph node—jejunal cancer	0.000895	0.0102	CbGeAlD
Sorafenib—TAOK2—lymph node—jejunal cancer	0.000888	0.0101	CbGeAlD
Sorafenib—AURKC—lymph node—jejunal cancer	0.000881	0.01	CbGeAlD
Sorafenib—UGT1A9—endocrine gland—jejunal cancer	0.000858	0.00975	CbGeAlD
Sorafenib—KDR—smooth muscle tissue—jejunal cancer	0.000852	0.00968	CbGeAlD
Sorafenib—FLT4—endocrine gland—jejunal cancer	0.000846	0.00961	CbGeAlD
Sorafenib—CSF1R—smooth muscle tissue—jejunal cancer	0.000831	0.00945	CbGeAlD
Sorafenib—FLT1—lymphoid tissue—jejunal cancer	0.000806	0.00916	CbGeAlD
Sorafenib—RAF1—lymphoid tissue—jejunal cancer	0.000801	0.0091	CbGeAlD
Sorafenib—ZAK—lymph node—jejunal cancer	0.000773	0.00879	CbGeAlD
Sorafenib—MKNK2—endocrine gland—jejunal cancer	0.000765	0.0087	CbGeAlD
Sorafenib—STK10—lymphoid tissue—jejunal cancer	0.000762	0.00867	CbGeAlD
Sorafenib—HIPK3—lymph node—jejunal cancer	0.000757	0.0086	CbGeAlD
Sorafenib—MKNK1—endocrine gland—jejunal cancer	0.000756	0.00859	CbGeAlD
Sorafenib—KIT—smooth muscle tissue—jejunal cancer	0.000755	0.00858	CbGeAlD
Sorafenib—PDGFRA—lymphoid tissue—jejunal cancer	0.000755	0.00858	CbGeAlD
Sorafenib—RET—endocrine gland—jejunal cancer	0.000746	0.00849	CbGeAlD
Sorafenib—PDGFRB—smooth muscle tissue—jejunal cancer	0.000737	0.00838	CbGeAlD
Sorafenib—CYP3A7—endocrine gland—jejunal cancer	0.000713	0.00811	CbGeAlD
Sorafenib—TIE1—lymph node—jejunal cancer	0.000707	0.00804	CbGeAlD
Sorafenib—KIT—pancreas—jejunal cancer	0.000698	0.00793	CbGeAlD
Sorafenib—RALBP1—endocrine gland—jejunal cancer	0.000691	0.00786	CbGeAlD
Sorafenib—PDGFRB—pancreas—jejunal cancer	0.000682	0.00775	CbGeAlD
Sorafenib—KDR—lymphoid tissue—jejunal cancer	0.000681	0.00774	CbGeAlD
Sorafenib—BRAF—lymph node—jejunal cancer	0.000678	0.00771	CbGeAlD
Sorafenib—CSF1R—lymphoid tissue—jejunal cancer	0.000665	0.00755	CbGeAlD
Sorafenib—FLT1—endocrine gland—jejunal cancer	0.000657	0.00747	CbGeAlD
Sorafenib—RAF1—endocrine gland—jejunal cancer	0.000654	0.00743	CbGeAlD
Sorafenib—EPHX2—lymph node—jejunal cancer	0.000648	0.00737	CbGeAlD
Sorafenib—FLT3—lymph node—jejunal cancer	0.000644	0.00732	CbGeAlD
Sorafenib—STK10—endocrine gland—jejunal cancer	0.000622	0.00707	CbGeAlD
Sorafenib—PDGFRA—endocrine gland—jejunal cancer	0.000616	0.007	CbGeAlD
Sorafenib—KIT—lymphoid tissue—jejunal cancer	0.000603	0.00686	CbGeAlD
Sorafenib—PDGFRB—lymphoid tissue—jejunal cancer	0.000589	0.0067	CbGeAlD
Sorafenib—UGT1A1—endocrine gland—jejunal cancer	0.000588	0.00668	CbGeAlD
Sorafenib—FLT4—lymph node—jejunal cancer	0.000585	0.00664	CbGeAlD
Sorafenib—HTR2B—smooth muscle tissue—jejunal cancer	0.000584	0.00664	CbGeAlD
Sorafenib—FGFR1—lymph node—jejunal cancer	0.000577	0.00655	CbGeAlD
Sorafenib—MAP2K5—endocrine gland—jejunal cancer	0.000556	0.00632	CbGeAlD
Sorafenib—KDR—endocrine gland—jejunal cancer	0.000556	0.00632	CbGeAlD
Sorafenib—MAP3K7—lymph node—jejunal cancer	0.000546	0.00621	CbGeAlD
Sorafenib—ABCC4—pancreas—jejunal cancer	0.000543	0.00617	CbGeAlD
Sorafenib—CSF1R—endocrine gland—jejunal cancer	0.000542	0.00617	CbGeAlD
Sorafenib—MKNK2—lymph node—jejunal cancer	0.000529	0.00601	CbGeAlD
Sorafenib—MKNK1—lymph node—jejunal cancer	0.000522	0.00594	CbGeAlD
Sorafenib—RET—lymph node—jejunal cancer	0.000516	0.00587	CbGeAlD
Sorafenib—KIT—endocrine gland—jejunal cancer	0.000493	0.0056	CbGeAlD
Sorafenib—PDGFRB—endocrine gland—jejunal cancer	0.000481	0.00547	CbGeAlD
Sorafenib—RALBP1—lymph node—jejunal cancer	0.000478	0.00543	CbGeAlD
Sorafenib—FLT1—lymph node—jejunal cancer	0.000454	0.00517	CbGeAlD
Sorafenib—RAF1—lymph node—jejunal cancer	0.000452	0.00514	CbGeAlD
Sorafenib—EPHB6—lymph node—jejunal cancer	0.000449	0.00511	CbGeAlD
Sorafenib—STK10—lymph node—jejunal cancer	0.00043	0.00489	CbGeAlD
Sorafenib—PDGFRA—lymph node—jejunal cancer	0.000426	0.00484	CbGeAlD
Sorafenib—MAP2K5—lymph node—jejunal cancer	0.000384	0.00437	CbGeAlD
Sorafenib—KDR—lymph node—jejunal cancer	0.000384	0.00437	CbGeAlD
Sorafenib—ABCC4—endocrine gland—jejunal cancer	0.000383	0.00435	CbGeAlD
Sorafenib—CSF1R—lymph node—jejunal cancer	0.000375	0.00426	CbGeAlD
Sorafenib—ABCC2—endocrine gland—jejunal cancer	0.000371	0.00421	CbGeAlD
Sorafenib—CYP3A5—pancreas—jejunal cancer	0.000356	0.00404	CbGeAlD
Sorafenib—KIT—lymph node—jejunal cancer	0.00034	0.00387	CbGeAlD
Sorafenib—PDGFRB—lymph node—jejunal cancer	0.000333	0.00378	CbGeAlD
Sorafenib—CYP2C19—endocrine gland—jejunal cancer	0.000319	0.00362	CbGeAlD
Sorafenib—CYP2B6—lymphoid tissue—jejunal cancer	0.000306	0.00347	CbGeAlD
Sorafenib—CYP2C8—endocrine gland—jejunal cancer	0.000278	0.00316	CbGeAlD
Sorafenib—ABCC4—lymph node—jejunal cancer	0.000265	0.00301	CbGeAlD
Sorafenib—HTR2B—lymph node—jejunal cancer	0.000263	0.00299	CbGeAlD
Sorafenib—CYP1A2—endocrine gland—jejunal cancer	0.00026	0.00296	CbGeAlD
Sorafenib—ABCC2—lymph node—jejunal cancer	0.000256	0.00291	CbGeAlD
Sorafenib—CYP3A5—endocrine gland—jejunal cancer	0.000251	0.00285	CbGeAlD
Sorafenib—CYP2B6—endocrine gland—jejunal cancer	0.000249	0.00284	CbGeAlD
Sorafenib—CYP2C9—endocrine gland—jejunal cancer	0.000247	0.00281	CbGeAlD
Sorafenib—ABCB1—pancreas—jejunal cancer	0.000189	0.00215	CbGeAlD
Sorafenib—CYP3A4—endocrine gland—jejunal cancer	0.000188	0.00214	CbGeAlD
Sorafenib—ABCG2—lymph node—jejunal cancer	0.000187	0.00212	CbGeAlD
Sorafenib—CYP2D6—endocrine gland—jejunal cancer	0.000185	0.00211	CbGeAlD
Sorafenib—ABCB1—lymphoid tissue—jejunal cancer	0.000163	0.00186	CbGeAlD
Sorafenib—ABCB1—endocrine gland—jejunal cancer	0.000133	0.00152	CbGeAlD
Sorafenib—ABCB1—lymph node—jejunal cancer	9.22e-05	0.00105	CbGeAlD
